{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:46:00Z","timestamp":1791071160703,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T00:00:00Z","timestamp":1348358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10048-012-0344-7","type":"journal-article","created":{"date-parts":[[2012,9,22]],"date-time":"2012-09-22T03:44:47Z","timestamp":1348285487000},"page":"71-75","source":"Crossref","is-referenced-by-count":61,"title":["Refining the phenotype associated with MEF2C point mutations"],"prefix":"10.1007","volume":"14","author":[{"given":"Thierry","family":"Bienvenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Chelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Isidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,23]]},"reference":[{"key":"344_CR1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/ejhg.2009.90","volume":"17","author":"H Engels","year":"2009","unstructured":"Engels H, Wohlleber E, Zink A, Hoyer J, Ludwig KU, Brockschmidt FF, Wieczorek D, Moog U, Hellmann-Mersch B, Weber RG, Willatt L, Kreiss-Nachtsheim M, Firth HV, Rauch A (2009) A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients. Eur J Hum Genet 17:1592\u20131599","journal-title":"Eur J Hum Genet"},{"key":"344_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/01.wnl.0000336339.08878.2d","volume":"72","author":"C Cardoso","year":"2009","unstructured":"Cardoso C, Boys A, Parrini E, Mignon-Ravix C, McMahon JM, Khantane S, Bertini E, Pallesi E, Missirian C, Zuffardi O, Novara F, Villard L, Giglio S, Chabrol B, Slater HR, Moncla A, Scheffer IE, Guerrini R (2009) Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology 72:784\u2013792","journal-title":"Neurology"},{"key":"344_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jmg.2009.069732","volume":"47","author":"N Meur Le","year":"2010","unstructured":"Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, Auvin S, Boucher C, Kerckaert JP, David V, Manouvrier-Hanu S, Saugier-Veber P, Fr\u00e9bourg T, Dubourg C, Andrieux J, Bonneau D (2010) MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and\/or cerebral malformations. J Med Genet 47:22\u201329","journal-title":"J Med Genet"},{"key":"344_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/humu.21253","volume":"31","author":"M Zweier","year":"2010","unstructured":"Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, Grasshoff U, Johnson DS, Robertson L, Firth HV, Cornelia K, Ekici AB, Reis A, Rauch A (2010) Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum Mutat 31:722\u2013733","journal-title":"Hum Mutat"},{"key":"344_CR5","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/ajmg.a.34289","volume":"155A","author":"H Saitsu","year":"2011","unstructured":"Saitsu H, Igarashi N, Kato M, Okada I, Kosho T, Shimokawa O, Sasaki Y, Nishiyama K, Tsurusaki Y, Doi H, Miyake N, Harada N, Hayasaka K, Matasumoto N (2011) De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy. Am J Med Genet A 155A:2879\u20132884","journal-title":"Am J Med Genet A"},{"key":"344_CR6","doi-asserted-by":"crossref","unstructured":"Shimojima K, Okumura A, Mori H, Abe S, Ikeno M, Shimizu T, Yamamoto T (2012) De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum. Am J Med Genet A. doi: 10.1002\/ajmg.a.35490 , Epub ahead of print","DOI":"10.1002\/ajmg.a.35490"},{"key":"344_CR7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000337496","volume":"2","author":"M Zweier","year":"2012","unstructured":"Zweier M, Rauch A (2012) The MEF2C-related and 5q14.3q15 microdeletion syndrome. Mol Syndromol 2:164\u2013170","journal-title":"Mol Syndromol"},{"key":"344_CR8","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","volume":"134","author":"MJ Potthoff","year":"2007","unstructured":"Potthoff MJ, Olson EN (2007) MEF2: a central regulation of diverse developmental programs. Development 134:4131\u20134140","journal-title":"Development"},{"key":"344_CR9","doi-asserted-by":"crossref","first-page":"17199","DOI":"10.1074\/jbc.271.29.17199","volume":"271","author":"JD Molkentin","year":"1996","unstructured":"Molkentin JD, Li L, Olson EN (1996) Phosphorylation of the MADS-box transcription factor MEF2C enhances its DNA biding activity. J Biol Chem 271:17199\u201317204","journal-title":"J Biol Chem"},{"key":"344_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0169-328X(01)00187-5","volume":"97","author":"CG Janson","year":"2001","unstructured":"Janson CG, Chen Y, Li Y, Leifer D (2001) Functional regulatory regions of human transcription factor MEF2C. Brain Res Mol Brain Res 97:70\u201382","journal-title":"Brain Res Mol Brain Res"},{"key":"344_CR11","unstructured":"Lambert L, Bienvenu T, Allou L, Valduga M, Echenne B, Diebold B, Mignot C, H\u00e9ron D, Roth V, Saunier A, Mousta\u00efne A, Jonveaux P, Philippe C (2012) MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies. Clin Genet Mar 26. doi: 10.1111\/j.1399-0004.2012.01861"},{"key":"344_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ajmg.a.34206","volume":"158A","author":"R Armani","year":"2012","unstructured":"Armani R, Archer H, Clarke A, Vasudevan P, Zweier C, Ho G, Williamson S, Cloosterman D, Yang N, Christodoulou J (2012) Transcription factor 4 and myocyte enhancer factor 2C mutations are not common causes of Rett syndrome. Am J Med Genet A 158A:713\u2013719","journal-title":"Am J Med Genet A"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-012-0344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-012-0344-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-012-0344-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:02:39Z","timestamp":1559116959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-012-0344-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,23]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1007\/s10048-012-0344-7","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,23]]}}}